Reference is made to Carasent ASA’s stock exchange and press release 30 August 2024 regarding the merger plan for a cross-border merger with Carasent AB (publ) (“Carasent SWE”) to the effect that shareholders will have their Carasent ASA shares one for one exchanged with Carasent SWE shares listed only on Nasdaq Stockholm (the “Relisting”) and to the stock exchange and press release published on 5 December 2024 regarding the completion of the cross-border merger with Carasent SWE. Upon completion of the merger, shareholders of Carasent ASA, including the following primary insiders, had their shares in Carasent ASA exchanged one-for-one with shares in Carasent SWE:

• G2 Invest Oy, a legal person closely associated with Petri Niemi, chairman of Carasent ASA’s board of directors (the “Board”) had 12,264 shares in Carasent ASA exchanged for 12,264 shares in Carasent SWE;
• NRG Nordiska Resultatgruppen AB, a legal person closely associated with member of the Board, Henric Carlsson, had 10,000 shares in Carasent ASA exchanged for 10,000 shares in Carasent SWE;
• Camilla Skoog, member of the Board, had 9,345 shares in Carasent ASA exchanged for 9,345 shares in Carasent SWE;
• Ulrika Cederskog Sundling, member of the Board, had 20,000 shares in Carasent ASA exchanged for 20,000 shares in Carasent SWE;
• Daniel Öhman, CEO, had 161,115 shares in Carasent ASA exchanged for 161,115 shares in Carasent SWE;
• Svein Martin Bjørnstad, CFO, had 78,017 shares in Carasent ASA exchanged for 78,017 shares in Carasent SWE, and, through his holding companies, Birgen Invest I AS and Birgen Invest II AS, he had, respectively, 125,628 and 150,000 shares in Carasent ASA exchanged for 125,628 and 150,000 shares in Carasent SWE;
• Vilma Jonson, Head of Strategy, had 24,132 shares in Carasent ASA exchanged for 24,132 shares in Carasent SWE;
• Cornelia Broqvist, Head of Marketing, had 2,403 shares in Carasent ASA exchanged for 2,403 shares in Carasent SWE;
• Stefan Jernberg, Head of Compliance, had 2,600 shares in Carasent ASA exchanged for 2,600 shares in Carasent SWE;
• Ad-Ma Holding AS, a legal person closely associated with Magnar Høyvik, Head of Department, had 120,000 shares in Carasent ASA exchanged for 120,000 shares in Carasent SWE;
• Björn Jacobson, CEO Medrave, had 18,832 shares in Carasent ASA exchanged for 18,832 shares in Carasent SWE;
• Nellie Förvaltning AB, a legal person closely associated with Björn Jacobson, CEO Medrave, had 28,256 shares in Carasent ASA exchanged for 28,256 shares in Carasent SWE;
• Thim Invest AS, a legal person closely associated with Ingvild Skarestad, CEO Norway, had 143,189 shares in Carasent ASA exchanged for 143,189 shares in Carasent SWE; and
• Nine Bean Rows AB, a legal person closely associated with Peter Wallin, CEO HPI AB, had 21,221 shares in Carasent ASA exchanged for 21,221 shares in Carasent SWE.

Furthermore, reference is made to the stock exchange and press release published by Carasent ASA on 27 September 2024 regarding the agreements between Carasent ASA and the CEO and chairman to cancel previously issued warrants against refund of the purchase price paid in connection with completion of the merger and the Relisting. In accordance therewith, all the 260,588 warrants held by the CEO and all the 260,588 warrants held by the chairman, have been cancelled, against a refund of the purchase price paid, i.e. NOK 800,000 each. The refunded amounts will as previously disclosed be used by the CEO and chairman in open-market purchase of shares in Carasent SWE.

Please see attached notification forms pursuant to article 19 of the Market Abuse Regulation.

For further details please contact:

Svein Martin Bjørnstad, CFO Tel: +47 979 69 493

This information is subject of the disclosure requirements pursuant to article 19 of the Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Ac